Skip to main content
Top
Published in: Endocrine 1/2019

01-07-2019 | Obesity | Original Article

Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China

Authors: Xin Huang, Qiuyi Wang, Tingting Liu, Tianjiao Pei, Dong Liu, Huili Zhu, Wei Huang

Published in: Endocrine | Issue 1/2019

Login to get access

Abstract

Purpose

Insulin resistance (IR) is a common feature of polycystic ovary syndrome (PCOS). Body fat indices can be predictive markers of IR. This study is aimed to predict IR in Chinese women with PCOS of different body types based on body fat indices.

Methods

A total of 723 women diagnosed with PCOS according to Rotterdam criteria were recruited in this study and were further divided into two groups based on their BMI. All participants underwent physical examinations and ultrasound; and blood was collected from them on the days 3–5 of the menstrual cycle. Their BMI, waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), lipid accumulation product (LAP) index, visceral adiposity index (VAI), and the homeostasis model assessment index of insulin resistance (HOMA-IR) were calculated. The correlations between body fat indices and HOMA-IR and receiver operating characteristic (ROC) curves were evaluated.

Results

In normal weight group (BMI < 24, n = 333), VAI (best cut-off value: 1.681, area under curve (AUC) = 0.754, P < 0.01) and LAP index (best cut-off value: 18.53, AUC = 0.734, P < 0.001) were the reliable indicators of IR based on HOMA-IR ≥ 2.77, while in overweight/obese group (BMI ≥ 24, n = 390), the BMI, WC, WHtR and LAP index had a significant correlation with HOMA-IR. The representative markers to assess IR were BMI (best cut-off value: 26.43, AUC = 0.644, P = 0.001) and WHtR (best cut-off value: 0.544, AUC = 0.604, P = 0.021).

Conclusions

Body fat indices are predictive markers of IR in Chinese PCOS women, especially in those with normal weight.
Literature
2.
go back to reference A. Deeks, H. Teede, L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC. Med. 8(1), 41 (2010)CrossRef A. Deeks, H. Teede, L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC. Med. 8(1), 41 (2010)CrossRef
3.
go back to reference E. Diamantikandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981–1030 (2012)CrossRef E. Diamantikandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981–1030 (2012)CrossRef
4.
go back to reference D. Wiltgen, I.G. Benedetto, L.S. Mastella, P.M. Spritzer, Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum. Reprod. 24(7), 1726–1731 (2009)CrossRef D. Wiltgen, I.G. Benedetto, L.S. Mastella, P.M. Spritzer, Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum. Reprod. 24(7), 1726–1731 (2009)CrossRef
5.
go back to reference L.N. Matos, G.V. Giorelli, C.B. Dias, Correlation of anthropometric indicators for identifying insulin sensitivity and resistance. Sao Paulo Med. J. 129(1), 30–35 (2011)CrossRef L.N. Matos, G.V. Giorelli, C.B. Dias, Correlation of anthropometric indicators for identifying insulin sensitivity and resistance. Sao Paulo Med. J. 129(1), 30–35 (2011)CrossRef
6.
go back to reference J.Y. Oh, Y.A. Sung, H.J. Lee et al. Optimal waist circumference for prediction of metabolic syndrome in young korean women with polycystic ovary syndrome. Obesity 18(3), 593–597 (2010)CrossRef J.Y. Oh, Y.A. Sung, H.J. Lee et al. Optimal waist circumference for prediction of metabolic syndrome in young korean women with polycystic ovary syndrome. Obesity 18(3), 593–597 (2010)CrossRef
7.
go back to reference F. Ramezani Tehrani, S. Minooee, F. Azizi, Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Eur. J. Endocrinol. 171(2), 199–207 (2014)CrossRef F. Ramezani Tehrani, S. Minooee, F. Azizi, Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Eur. J. Endocrinol. 171(2), 199–207 (2014)CrossRef
8.
go back to reference A.K.C. Roriz, L.C.S. Passos, C.C. de Oliveira et al. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS ONE 9(7), E103499 (2014)CrossRef A.K.C. Roriz, L.C.S. Passos, C.C. de Oliveira et al. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS ONE 9(7), E103499 (2014)CrossRef
9.
go back to reference M.C. Amato, A. Magistro, G. Gambino, R. Vesco, C. Giordano, Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome. Eur. J. Endocrinol. 172(1), 79–88 (2015)CrossRef M.C. Amato, A. Magistro, G. Gambino, R. Vesco, C. Giordano, Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome. Eur. J. Endocrinol. 172(1), 79–88 (2015)CrossRef
10.
go back to reference J.X. Prado Teixeira Nascimento, M.B. da Costa Chein, Lopes, R.M. de Sousa, Ad.S. Ferreira, P.A. Navarro, L.M. Oliveira Brito, Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 14, 62 (2015)CrossRef J.X. Prado Teixeira Nascimento, M.B. da Costa Chein, Lopes, R.M. de Sousa, Ad.S. Ferreira, P.A. Navarro, L.M. Oliveira Brito, Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 14, 62 (2015)CrossRef
11.
go back to reference G.A. Abruzzese, G.E. Cerrrone, J.M. Gamez et al. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm. Metab. Res. 49(1), 23–29 (2017)PubMed G.A. Abruzzese, G.E. Cerrrone, J.M. Gamez et al. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm. Metab. Res. 49(1), 23–29 (2017)PubMed
12.
go back to reference J.L. Chan, S. Kar, E. Vanky et al. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am. J. Obstet. Gynecol. 2, 189.e1–189.e8 (2017)CrossRef J.L. Chan, S. Kar, E. Vanky et al. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am. J. Obstet. Gynecol. 2, 189.e1–189.e8 (2017)CrossRef
13.
go back to reference B. Fauser, J. Chang, R. Azziz et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41–47 (2004)CrossRef B. Fauser, J. Chang, R. Azziz et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41–47 (2004)CrossRef
14.
go back to reference B. Zhou, Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin. J. Epidemiol. 23(1), 5–10 (2002) B. Zhou, Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin. J. Epidemiol. 23(1), 5–10 (2002)
15.
go back to reference S.S.C. Yen, B.B. Jaffe, R.L. Barbieri. Reproductive Endocrinology. 4th edn. (Science, Harcourt Asia, W. B. Saunders, Print, Beijing, 2001) S.S.C. Yen, B.B. Jaffe, R.L. Barbieri. Reproductive Endocrinology. 4th edn. (Science, Harcourt Asia, W. B. Saunders, Print, Beijing, 2001)
16.
go back to reference H.S. Kahn, The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc. Disord. 5, 26 (2005)CrossRef H.S. Kahn, The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc. Disord. 5, 26 (2005)CrossRef
17.
go back to reference M.C. Amato, C. Giordano, M. Galia et al. Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4), 920–922 (2010)CrossRef M.C. Amato, C. Giordano, M. Galia et al. Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4), 920–922 (2010)CrossRef
18.
go back to reference M. Li, R.A. McDermott, Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Diabetes Res. Clin. Pract. 87(3), 401–406 (2010)CrossRef M. Li, R.A. McDermott, Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Diabetes Res. Clin. Pract. 87(3), 401–406 (2010)CrossRef
19.
go back to reference X. Guan, G. Sun, L. Zheng, W. Hu, W. Li, Y. Sun, Associations between metabolic risk factors and body mass index, waist circumference, waist-to-height ratio and waist-to-hip ratio in a Chinese rural population. J. Diabetes Invest. 7(4), 601–606 (2016)CrossRef X. Guan, G. Sun, L. Zheng, W. Hu, W. Li, Y. Sun, Associations between metabolic risk factors and body mass index, waist circumference, waist-to-height ratio and waist-to-hip ratio in a Chinese rural population. J. Diabetes Invest. 7(4), 601–606 (2016)CrossRef
20.
go back to reference P. Dou, H. Ju, J. Shang et al. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women. J. Ovarian Res. 9(1), 51 (2016)CrossRef P. Dou, H. Ju, J. Shang et al. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women. J. Ovarian Res. 9(1), 51 (2016)CrossRef
21.
go back to reference I.I. Androulakis, E. Kandaraki, C. Christakou et al. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin. Endocrinol. 81(3), 426–431 (2014)CrossRef I.I. Androulakis, E. Kandaraki, C. Christakou et al. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin. Endocrinol. 81(3), 426–431 (2014)CrossRef
22.
go back to reference X. Chen, R. Ni, Y. Mo, L. Li, D.Z. Yang, Appropriate BMI levels for PCOS patients in Southern China. Hum. Reprod. 25(5), 1295–1302 (2010)CrossRef X. Chen, R. Ni, Y. Mo, L. Li, D.Z. Yang, Appropriate BMI levels for PCOS patients in Southern China. Hum. Reprod. 25(5), 1295–1302 (2010)CrossRef
23.
go back to reference J.A. Nazare, J.D. Smith, A.L. Borel et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra-Abdominal Adiposity. Am. J. Clin. Nutr. 96(4), 714–726 (2012)CrossRef J.A. Nazare, J.D. Smith, A.L. Borel et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra-Abdominal Adiposity. Am. J. Clin. Nutr. 96(4), 714–726 (2012)CrossRef
24.
go back to reference T. Du, X. Yu, J. Zhang, X. Sun, Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol. 52(5), 855–863 (2015)CrossRef T. Du, X. Yu, J. Zhang, X. Sun, Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol. 52(5), 855–863 (2015)CrossRef
25.
go back to reference Z. Huang, E.L. Yong, Ethnic differences: is there an Asian phenotype for polycystic ovarian syndrome? Best Pract. Res. Clin. Obstet. Gynaecol. 37, 46–55 (2016)CrossRef Z. Huang, E.L. Yong, Ethnic differences: is there an Asian phenotype for polycystic ovarian syndrome? Best Pract. Res. Clin. Obstet. Gynaecol. 37, 46–55 (2016)CrossRef
Metadata
Title
Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China
Authors
Xin Huang
Qiuyi Wang
Tingting Liu
Tianjiao Pei
Dong Liu
Huili Zhu
Wei Huang
Publication date
01-07-2019
Publisher
Springer US
Published in
Endocrine / Issue 1/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01912-1

Other articles of this Issue 1/2019

Endocrine 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.